FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

376645003: Cytarabine liposomal 50mg/5mL injection 5mL vial (product)


    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    2463818018 Cytarabine liposomal 50mg/5mL injection 5mL vial (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    2470300010 Cytarabine liposomal 50mg/5mL injection 5mL vial en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    4645351000005111 liposomalt cytarabin 50 mg/5 ml injektionsvæske, hætteglas a 5 ml da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    liposomalt cytarabin 50 mg/5 ml injektionsvæske, hætteglas a 5 ml Is a Product containing cytarabine (medicinal product) false Inferred relationship Some
    liposomalt cytarabin 50 mg/5 ml injektionsvæske, hætteglas a 5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Pyrimidine analog (substance) false Inferred relationship Some
    liposomalt cytarabin 50 mg/5 ml injektionsvæske, hætteglas a 5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Cytarabine (substance) false Inferred relationship Some
    liposomalt cytarabin 50 mg/5 ml injektionsvæske, hætteglas a 5 ml Has manufactured dose form injektionsvæske false Inferred relationship Some
    liposomalt cytarabin 50 mg/5 ml injektionsvæske, hætteglas a 5 ml Is a liposomalt cytarabin false Inferred relationship Some
    liposomalt cytarabin 50 mg/5 ml injektionsvæske, hætteglas a 5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Cytarabine liposome false Inferred relationship Some
    liposomalt cytarabin 50 mg/5 ml injektionsvæske, hætteglas a 5 ml Is a Product manufactured as parenteral dose form (product) false Inferred relationship Some
    liposomalt cytarabin 50 mg/5 ml injektionsvæske, hætteglas a 5 ml Is a Cytarabine-containing product in parenteral dose form false Inferred relationship Some

    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start